Metastatic superscan in prostate carcinoma on gallium-68-prostate-specific membrane antigen positron emission tomography/computed tomography scan.
We describe the imaging features of a metastatic superscan on gallium-68 Glu-NH-CO-NH-Lys-(Ahx)-[Ga-68(HBED-CC)], abbreviated as gallium-68-prostate-specific membrane antigen ((68)Ga-PSMA) positron emission tomography/computed tomography (PET/CT) imaging. (68)Ga-PSMA is novel radiotracer undergoing evaluation for PET/CT imaging of prostate carcinoma. This patient had a superscan of metastases on conventional bone scintigraphy and was referred for (68)Ga-PSMA PET/CT to evaluate the feasibility of (177)Lu-PSMA therapy.
Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Krishan Kant
KK
Agarwal
Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Madhavi
M
Tripathi
Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Rajeev
R
Kumar
Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Chandrasekhar
C
Bal
Gallium-68-prostate-specific membrane antigen; metastasis; positron emission tomography/computed tomography; prostate carcinoma